Get the app!
Back to Trades

Kulkarni Samarth

InsiderCIK 0001682019

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
13
Buy transactions
0
Sell transactions
9
Companies
4
Active
2025–2026

Kulkarni Samarth accounts for 13 disclosed filings worth $22.6M, spread across 4 companies, active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $10.8M in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

13 loaded
Jun 29BDTX
Black Diamond Therapeutics, Inc.
Kulkarni SamarthInsiderAward$68.4K
Jun 24CNTA
Centessa Pharmaceuticals plc
Kulkarni SamarthDirectorDisposed$2.7M
Jun 3ORKA
Oruka Therapeutics, Inc.
Kulkarni SamarthDirectorAward$504.6K
Mar 24CRSP
CRISPR Therapeutics AG
Kulkarni SamarthInsiderSell$468.7K
Mar 17CRSP
CRISPR Therapeutics AG
Kulkarni SamarthInsiderSell$499.4K
Mar 12CRSP
CRISPR Therapeutics AG
Kulkarni SamarthInsiderSell$517.3K
Feb 20CRSP
CRISPR Therapeutics AG
Kulkarni SamarthInsiderSell$366.3K
Jan 22CRSP
CRISPR Therapeutics AG
Kulkarni SamarthInsiderSell$5.2M
Dec 22CRSP
CRISPR Therapeutics AG
Kulkarni SamarthInsiderGift$0
Oct 20CRSP
CRISPR Therapeutics AG
Kulkarni SamarthInsiderSell$3.5M
Oct 15CRSP
CRISPR Therapeutics AG
Kulkarni SamarthInsiderSell$282.5K
Oct 3CRSP
CRISPR Therapeutics AG
Kulkarni SamarthInsiderAward$3.4M
Sep 19CRSP
CRISPR Therapeutics AG
Kulkarni SamarthInsiderGift$0

13 filings